Connect with us

Maryland

Maryland men’s lacrosse has gotten off to an inefficient start

Published

on

Maryland men’s lacrosse has gotten off to an inefficient start


Braden Erksa surveyed the defense from behind the cage. He stood idle for nearly 20 seconds, waiting for a teammate to find separation. Nobody could.

No. 4 Maryland’s offense was stagnant and Erksa decided he would take it upon himself to score. He wrapped around the right side of the goal while the congestion of Terps and Greyhounds stood a few yards away from him.

Erksa turned his hip, leaped and fired a bounce shot that missed poorly. The possession was wasted as the unit failed to find a flow — a continued issue for Maryland men’s lacrosse.

“I feel like we’ve been reckless and kind of forcing things,” coach John Tillman said. “If you don’t have it, just don’t turn it into all or nothing. Move it to the next guy and let’s keep putting pressure on their guys.”

Advertisement

Last season marked the Terps’ worst campaign in a decade, with their offensive struggles to blame. Their shooting percentage and efficiency marked the program’s worst in recent seasons.

Maryland’s offensive troubles have remained through two games this season despite its perfect start. The unit followed a 33 percent shooting performance in the season-opener with a 23 percent outing in its second game.

[No. 4 Maryland men’s lacrosse wins defensive battle with No. 12 Loyola, 11-4]

One of the highlights of the attack last year was Erksa, whose excellent campaign garnered him Big Ten Freshman of the Year honors. He started this season with a hat trick against Richmond but scored just one goal on 10 attempts against No. 12 Loyola on Saturday.

The score showcased Erksa’s strong shot power but came unguarded off a transition feed — the sophomore has struggled at times in a set offense.

Advertisement

Eric Malever played a key role as a starter in the program’s undefeated national championship in 2022. The Terps were without Malever last year as he missed the entire season with leg injuries, limiting the offense’s capabilities. The former five-star recruit is healthy but has returned to a shaky start in 2024, connecting on just two of 11 shots through two games.

“We’re just gonna have to keep working, keep shooting our shots,” Malever said. “Shots are gonna fall. We’ll keep getting great game plans by our coaches and we’re gonna keep getting better.”

Erksa and Malever are two of three Terps to total at least 10 shots through two contests. Daniel Maltz, fresh off a two-goal outing against Loyola, has tallied 14 attempts. All three players have shot below 30 percent this season.

[Maryland men’s lacrosse reserves the No. 1 for program standouts. Enter Ajax Zappitello.]

Maryland’s troubles on offense go beyond its leading trio. Of every player to record at least two shots so far, the lone Terp shooting more than 35 percent is Ryan Siracusa. The team’s 27.7 overall shooting percentage ranks No. 36 in the country, and its 27.1 percent offensive efficiency ranks No. 33.

Advertisement

Maryland’s offense hit lulls against both Richmond and Loyola, going scoreless for spans of at least eight minutes three times in each game.

“Our mindset is 0-0 no matter what,” Malever said. “Having that next-play mentality is really big for us.”

The Terps’ offense has struggled when they go deep into the shot clock. They’ve needed to rely on early looks from unlikely places to find sparks, like Ajax Zappitello’s transition score against Richmond and Colin Burlace’s pole goal just five seconds into the shot clock against Loyola.

“It’s so hard to score six-on-six, so if you have poles that can handle the ball … those are juice goals,” Tillman said.

Maryland is perfect through two games this season, but its offense hasn’t found much rhythm, especially in set pieces. The unit’s inefficiency held the Terps back last year — they’ll need more consistency as the campaign goes on.

Advertisement



Source link

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Maryland

Indiana basketball vs. Maryland start time, TV, stats, schedule

Published

on

Indiana basketball vs. Maryland start time, TV, stats, schedule


Indiana basketball has stayed over .500 for the season after snapping a four-game losing streak as it visits Maryland in Big Ten action.

The Hoosiers held off visiting Wisconsin despite another Malik Reneau foul out and a 20-minute fire alarm delay. IU had its best shooting night (61.7%) in 2024, including 6-of-14 3-pointers (42.9%). Kel’el Ware had a dominant performance with 27 points, 11 rebounds and 6 blocked shots.

Indiana team leaders: Reneau (16.0 points, 6.2 rebounds); Ware (15.6 points, 43.8% 3-pointers, 9.5 rebounds); Mackenzie Mgbako (11.6 points, 4.0 rebounds); Trey Galloway (10.6 points, 4.6 assists). Mike Woodson is in his third season as coach.

Advertisement

Maryland (15-14, 7-11) is coming off a loss to Northwestern. They Terrapins make 28.2% of their 3-pointers (among the nation’s worst), but they shoot 24 free throws per game (top 20 in the nation) and make 72%. They also hit the offensive boards well (10.6 per game).

Maryland team leaders: Jahmir Young (20.9 points, 4.8 rebounds, 4.2 assists, 1.3 steals); Julian Reese (13.9 points, 9.7 rebounds); Donta Scott (11.3 points, 4.9 rebounds). Kevin Willard is in his second season as coach.

Indiana beat Maryland 65-53 on Dec. 1 in Bloomington. Ware had 18 points and 14 rebounds, and Young had 20 points. The Hoosiers had 3 3-pointers and Maryland 2. IU had a 16-rebound advantage.

IU is 2-6 on the road and Maryland is 11-4 at home.

Advertisement

Indiana basketball NET ranking

Via the NCAA as of Feb. 29

Indiana, 105

Maryland, 69

IU basketball vs. Maryland start time

2 p.m. ET Sunday, March 3, 2024, at Xfinity Center in College Park, Maryland.

How watch Indiana basketball vs. Maryland

TV: CBS

Advertisement

Radio: Indiana Hoosiers Sports Network (105.1 FM in Bloomington, 93.1 FM in Indianapolis), with Don Fischer (play-by-play), Errek Suhr (analysis) and John Herrick (updates).

Streaming: SiriusXM Channel 381 and 971, Varsity Network, ESPN+, Fubo, Paramount+, Sling

Indiana basketball schedule

Date, day location, opponent time, TV
Oct. 29, Sunday vs. Indianapolis (exhibition) W, 74-52
Nov. 3, Friday vs. Marian (exhibition) W, 94-61
Nov. 7, Tuesday vs. Florida Gulf Coast W, 69-63
Nov. 12, Saturday vs. Army W, 72-64
Nov. 16, Thursday vs. Wright State W, 89-80
Nov. 19, Sunday vs. Connecticut in New York L, 77-57
Nov. 20, Monday vs. Louisville in New York W, 74-66
Nov. 26, Sunday vs. Harvard in Indianapolis W, 89-76
Dec. 1, Friday vs. Maryland W, 65-53
Dec. 5, Tuesday at Michigan W, 78-75
Dec. 9, Saturday vs. Auburn in Atlanta L, 104-76
Dec. 16, Saturday vs. Kansas L, 75-71
Dec. 19, Tuesday vs. Morehead State W, 69-68
Dec. 21, Thursday vs. North Alabama W, 83-66
Dec. 29, Friday vs. Kennesaw State W, 100-87
Jan. 3, Wednesday at Nebraska L, 86-70
Jan. 6, Saturday vs. Ohio State W, 71-65
Jan. 9, Tuesday at Rutgers L, 66-57
Jan. 12, Friday vs. Minnesota W, 74-62
Jan. 16, Tuesday vs. Purdue L, 87-66
Jan. 19, Friday at Wisconsin L, 91-79
Jan. 27, Saturday at Illinois L, 70-62
Jan. 30, Tuesday vs. Iowa W, 74-68
Feb. 3, Saturday vs. Penn State L, 85-71
Feb. 6, Tuesday at Ohio State W, 76-73
Feb. 10, Saturday at Purdue L, 79-59
Feb. 18, Sunday vs. Northwestern L, 76-72
Feb. 21, Wednesday vs. Nebraska L, 85-70
Feb. 24, Saturday at Penn State L, 83-74
Feb. 27, Tuesday vs. Wisconsin W, 74-70
March 3, Sunday at Maryland 2 p.m., CBS
March 6, Wednesday at Minnesota 9 p.m., BTN
March 10, Sunday vs. Michigan State 4:30 p.m., CBS
March 13-17 Big Ten tournament at Minneapolis



Source link

Continue Reading

Maryland

Northwestern beats Maryland for milestone victory

Published

on

Northwestern beats Maryland for milestone victory


COLLEGE PARK, Md. — Nick Martinelli scored a career-high 27 points, Brooks Barnhizer added 14 points and 10 rebounds and Northwestern held off Maryland 68-61 on Wednesday night.

The Wildcats (20-8, 11-6 Big Ten) made 28 of 31 free throws, including 10 for 10 by Barnhizer and 9 for 10 by Martinell, as they held on to third place in the Big Ten and reached 20 wins for only the sixth time in program history.

Jahmir Young made two free throws to get the Terrapins within two points with less than 10 minutes left in the second half, but the Wildcats responded and took their first double-digit lead of the game when Matthew Nicholson dunked for a 55-45 lead with 6 minutes to go.

Maryland didn’t fade, and a fastbreak layup by Young made it 60-55 with 3 minutes to go. The Terps forced a shot-clock violation on Northwestern’s next possession and Julian Reese converted a layup to get Maryland within 60-57. Northwestern scored the next four points to go up by seven with 51 seconds left and Barnhizer went 4-for-4 from the line to seal the victory.

Advertisement

Young scored 24 points and made 11 of 12 free throws for Maryland (15-14, 7-11). DeShawn Harris-Smith had 14 points and Reese 12. Maryland finished 17 for 24 from the line and made only 2 of 22 3-point tries.

Boo Buie had 12 points, four rebounds and five assists for Northwestern.

After six lead changes and six ties in the first 13 1/2 minutes, Northwestern moved out in front on a series of free throws by Martinelli, who went 8 for 8 from the line in the first half. He scored eight consecutive points for the Wildcats — all on free throws — helping them build a six-point lead with 5 minutes left in the half. The Wildcats led 29-24 after a first half in which they went 14 for 16 on free throws and Maryland made 13 of 16.

Northwestern hosts Iowa on Saturday in the first of three games in eight days to close out the regular season.

Maryland hosts Indiana on Sunday.

Advertisement





Source link

Continue Reading

Maryland

Maryland announces $238 million in new opioid settlements with Walgreens, Walmart, two drugmakers

Published

on

Maryland announces $238 million in new opioid settlements with Walgreens, Walmart, two drugmakers


Maryland’s top lawyer announced Wednesday afternoon that the state had reached settlements with Walgreens, Walmart and two opioid manufacturers that are expected to add $238 million to its efforts to fight the opioid crisis over the course of 15 years.

The settlements follow multi-year investigations of the roles of the opioid manufacturers and chain pharmacies in fueling Maryland’s opioid crisis, the Office of Maryland Attorney General Anthony G. Brown said in a news release.

Along with forcing the companies to pay out, the settlements also mandate that they “stop engaging in practices that gave rise to the opioid crisis and take steps to prevent further illegal conduct,” the news release said.

There were 2,600 fatal overdoses in Maryland from November 2022 to October 2023, according to state data. Fentanyl – a highly potent form of opioid – was involved in 80% of these deaths.

Advertisement

“The opioid epidemic has claimed thousands of innocent lives through addiction and overdoses, has torn families apart, and has devastated communities across this country,” Brown said in the release. “This settlement money will help support recovery efforts in Maryland and prevent future loss where we need it most.”

All revenue from the settlements will be placed in the Maryland Opioid Restitution Fund and be spent on efforts to ease the crisis, the news release said.

Two years ago, pharmaceutical manufacturer Johnson & Johnson and the country’s three largest pharmaceutical distributors agreed to pay the state and most of its localities about $395 million over the course of 18 years. In exchange, the state absolved the companies of liability for illegally marketing and distributing opioids before the settlements.

One of the opioid manufacturers involved in the latest settlements — Teva, which is based in Israel — marketed and sold extremely dangerous and addictive rapid-onset fentanyl products, according to the news release, which cites documents filed Wednesday morning in Frederick County Circuit Court.

The products — Actiq, a fentanyl lozenge resembling a lollipop, and Fentora, a fentanyl tablet — were approved by the U.S. Food and Drug Administration only to treat extreme pain in patients with advanced cancers that are unlikely to be cured. However, the release said, the company falsely claimed the drugs were safe for non-cancer conditions and funneled hundreds of thousands of dollars to at least 16 Maryland prescribers through a “bogus” speaker bureau.

Advertisement

This money, which the complaint describes as “kickbacks,” encouraged prescribers to write prescriptions for Actiq and Fentora for people who did not have cancer and should not have taken the drugs.

A former sales representative who provided sworn testimony to the Attorney General’s Opioids Unit claimed that Teva paid thousands of dollars in speaker fees, meals and drinks to three prescribers from the same Annapolis practice. These prescribers generally treated chronic non-cancer pain.

Under the settlement agreement, Teva will be required to pay restitution to the state for 13 years. The news release estimated that the state will bring in about $70.3 million from that agreement.

The complaint against the second opioid manufacturer, Allergan — now a part of AbbVie, headquartered in Chicago — alleges the company misled prescribers and patients about the relative safety of its extended-release morphine product, Kadian. The attorney general’s office said the company sold the product by deceptively marketing it as an option that was safer than other opioids.

The company also misled prescribers about the nature of addiction, the news release said, claiming that patients who were exhibiting the signs of addiction were not really addicted, but simply required more medicine to relieve their pain.

Advertisement

“These false messages led Maryland prescribers to increase opioids doses to those already suffering from addiction, contributing to the vast overprescription of opioids that fueled the opioids epidemic of addiction and death,” the attorney general’s office said.

Over the course of seven years, Allergan is expected to pay about $38.2 million to the state.

The biggest pay-out announced Wednesday comes from Walgreens, which is expected to pay $74.8 million over the course of 15 years for failing to protect their customers from inappropriate or unsafe prescription drugs.

Pharmacies are required by state and federal law to investigate opioid prescriptions that seem “problematic” before filling them, the attorney general’s office said. However, Walgreens and Walmart — which will pay the state about $55.5 million over the next six years — put inappropriate pressures on pharmacists and other pharmacy employees to fill prescriptions despite warning signs that showed the prescriptions might be unsafe.

This led both retailers to fill opioid prescriptions that were inappropriate and unsafe, “creating or contributing to the addiction and ultimate death of many Marylanders,” the news release said.

Advertisement

According to the news release, Walmart pharmacies filled prescriptions from health care providers at a now-shuttered pain management clinic in Baltimore County for 39 patients who later died from overdoses caused by opioid abuse and addiction. Walgreens pharmacies filled prescriptions for 116 patients from the same clinic who later died from overdoses.

“Walmart and Walgreens, the complaint charges, were aware of issues with the providers, but filled these and other prescriptions anyway, while deceiving the public that they were keeping consumers safe,” the news release said.



Source link

Continue Reading

Trending